Vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) show significant overlap with regard to their effects in the eye. It has been postulated that VEGF-induced leukostasis, breakdown of the blood-retinal barrier, and ischemia-induced retinal neovascularization may be mediated, at least in part, through TNF-α. In this study, we used mice deficient in TNF-α to test our hypothesis. Compared to wild type mice, TNF-α-deficient mice showed an 80% reduction in leukocyte accumulation in retinal vessels after intravitreous injection of VEGF, and 100% reductions after intravitreous injections of interleukin-1β (IL-1β) or platelet-activating factor (PAF). The increase in retinal vascular permeability induced by injection of PAF was significantly reduced in mice lacking TNF-α, but VEGF-and IL-1β-induced leakage was unaffected. Compared to wild type mice with oxygen-induced ischemic retinopathy, TNF-α-deficient mice with ischemic retinopathy showed significantly reduced leukostasis and mild reduction in vascular leakage, but no significant difference in retinal neovascularization. These data suggest that TNF-α mediates VEGF-, IL-1β-, and PAF-induced leukostasis and vascular leakage mediated by PAF, but not leakage caused by VEGF or IL-1β. Ischemia-induced retinal neovascularization, which has previously been shown to require VEGF, does not require TNF-α and is unaffected by attenuation of leukostasis.
Introduction
Retinal ischemia occurs in diabetic retinopathy, retinopathy of prematurity, retinal vein occlusions, and almost all retinal diseases complicated by retinal neovascularization (NV), and the causal link between retinal ischemia and retinal NV is well-established. It is also clear that vascular endothelial growth factor (VEGF) is increased in ischemic retina and is necessary for retinal NV to occur (Adamis et al., 1994; Aiello et al., 1994; Miller et al., 1994; Pierce et al., 1995; Ozaki et al., 2000) . What is not clear is whether other proteins with proangiogenic activity in other settings contribute to retinal NV and whether the angiogenic and vasopermeability activities of VEGF are dependent on the interaction of VEGF with another factor.
Fibroblast growth factor-2 (FGF-2) is a strong stimulator of endothelial cell proliferation in vitro and stimulates NV in some other tissues, but does not contribute to ocular NV (Tobe et al., 1998b; Yamada et al., 2001) . The situation regarding tumor necrosis factor-α (TNF-α) is even more 
